Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Azithromycin
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01FA
- Strength
- 200 mg/5 mL
- Dosage form
- Suspension
- Pack
- 15ml
- Registration no.
- 020957
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 268.17 to 351.58 (+31.1%) between 22 Aug 2025 and 25 Mar 2026 · 2 official price records · pack 15ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Resque 200 mg/5 mL, 15ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/resque-200-mg-5-ml-020957-15ml-standpharm-pakistan-pvt-ltd-17746/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 351.58 | 2026-03-25 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 268.17 | 2025-08-22 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 020957Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
